Very good exchange organised by the European House @Ambrosetti_ in Florence 🇮🇹 It is undisputed: to keep our health systems sustainable, prevention cannot remain undervalued. We also agreed that innovation is reshaping diagnostics, treatment & care and 🇪🇺 must lead this process. https://t.co/JdTIENBj5Y #HealthInnovation #SustainableHealthcare #PreventiveHealth #IT #EU
In the latest episode of "The Sunday Daily," host Rachel Abrams discusses recent breakthroughs in longevity science and cellular rejuvenation with New York Times Magazine writer Susan Dominus, exploring the potential implications of this research for the $2 trillion global wellness market focused on anti-aging products and treatments. #Longevity #HealthInnovation #AgingResearch #Nocountrycodesarestronglyreferencedinthearticle.
In this episode of "The Sunday Daily," hosted by Rachel Abrams, the discussion focuses on recent breakthroughs in the science of longevity, particularly cellular rejuvenation, and features insights from New York Times Magazine writer Susan Dominus on the implications of this research and its funding within the growing $2 trillion global wellness market aimed at reversing the aging process. #Longevity #Aging #HealthInnovation #Therearenospecificcountrymentionsinthearticleprovided.Therefore #theresponseis:
Maria Patzwald, a 38-year-old mother, participated in a pioneering trial aimed at treating preeclampsia—which affects many pregnancies and poses serious risks—by targeting a specific protein in the blood, leading to a successful extension of her pregnancy by two weeks and improving the chances of survival for her premature son. #Pregnancy #HealthInnovation #PreEclampsia #US #DE #GB
GLP-1 weight loss injections have emerged as a groundbreaking solution to the obesity crisis, with around 100 million users globally, as clinical trials and patient testimonials reveal significant weight loss results, although access issues and the high costs of these medications raise concerns about equitable treatment options in the UK. #WeightLoss #ObesityTreatment #HealthInnovation #GB #US #DK
After struggling for years to conceive, Chrissy Walters was diagnosed with advanced cervical cancer shortly after the birth of her daughter, prompting discussions about mortality from a young age, while Australia moves towards potentially eliminating this cancer through vaccination and screening programs by 2035. #CervicalCancer #Vaccination #HealthInnovation #AU #SE #RW #GB #US #VU #PG
A nine-year-old boy named Ezra, who has spinal muscular atrophy (SMA), has seen his life transformed by treatments recently approved for routine use in the NHS, allowing him to reach milestones that were once thought unattainable after a grim prognosis. #SpinalMuscularAtrophy #RareDiseases #HealthInnovation #GB
A stronger Europe means being prepared for future health crises. The Global Health Resilience Initiative should boost innovation, secure critical supply chains and reinforce Europe’s leadership in research, prevention and strategic resilience. #GlobalHealth #HealthInnovation #EULeadership #EU
A new daily pill, orforglipron, may help individuals who stop using injectable weight-loss medications maintain their weight loss, as research indicates that patients using the pill were able to keep over 70% of the weight they lost, while those on a placebo maintained only 38-50%, with the study highlighting orforglipron's potential benefits in managing obesity as a chronic disease. #WeightLoss #ObesityTreatment #HealthInnovation #US #GB
A new daily pill called orforglipron may help individuals maintain their weight loss after discontinuing GLP-1 injections, with a study showing those who took the pill retained over 70% of their weight loss, while side effects were generally mild, and further research is needed to determine the long-term necessity of the treatment. #WeightLoss #ObesityTreatment #HealthInnovation #US #UK
Recent research suggests that a new daily pill called orforglipron may help individuals transitioning off weight-loss injections maintain their slimness, with trials showing that participants taking the pill retained over 70% of their weight loss compared to 38-50% in the placebo group, though further studies are needed to determine the long-term effectiveness and duration of treatment. #WeightLoss #ObesityTreatment #HealthInnovation #US #UK
Patients at Birmingham's Queen Elizabeth Hospital are among the first in the UK to receive CAR-T cell therapy, an innovative and costly treatment for B-cell acute lymphoblastic leukaemia, which re-engineers patients' own immune cells to target their cancer, offering hope for remission and better long-term outcomes. #CancerTreatment #CARtherapy #HealthInnovation #GB
In a discussion on "The Ezra Klein Show," health journalist Julia Belluz explores the cultural phenomenon surrounding GLP-1 drugs, highlighting how their emergence coincides with our wellness-obsessed, algorithm-driven age, which fosters a biohacking culture and influences widespread interest in these medications for weight loss and improved focus. #HealthInnovation #Pharmaceuticals #WellnessCulture #CN
In a discussion on "The Ezra Klein Show," health journalist Julia Belluz explores how the popularity of GLP-1 drugs, like Wegovy and retatrutide, is influenced not only by their effectiveness in weight loss but also by the cultural obsession with wellness and social media that promotes biohacking and easy access to such substances. #HealthInnovation #Pharmaceuticals #WellnessCulture #CN
A new NHS community diagnostic centre in Epping, expected to enhance cancer diagnostics by allowing same-day testing and results, aims to improve the trust's previously criticized waiting times for treatment, while also receiving additional funding for future phases and new technology. #CancerCare #HealthInnovation #EarlyDiagnosis #GB
Health Minister Mike Nesbitt has announced that the injectable cancer immunotherapy drug Pembrolizumab (Keytruda) is already being used in three of Northern Ireland's five health trusts, streamlining treatment for patients with multiple cancers and aiming for broader availability across all trusts soon. #CancerTreatment #Immunotherapy #HealthInnovation #GB #NI #WA #EN
Health Minister Mike Nesbitt confirmed that the injectable cancer drug pembrolizumab (Keytruda), an immunotherapy used to treat multiple cancers, is already available in three of Northern Ireland's five health trusts, with plans for broader implementation to improve patient treatment efficiency. #CancerTreatment #Immunotherapy #HealthInnovation #GB #NI #ENG #WLS
There is a treatment capable of "reversing" Parkinson's disease. Moreover, it is a low-cost method, costing less than one dollar a day, based on megadosing vitamin B1 (thiamine). The Italian neurologist Antonio Costantini treats more than 2500. (Original: Il existe un traitement capable d’« inverser » la maladie de Parkinson. De surcroît, il s’agit d’une méthode bon marché, coûtant moins d’un dollar par jour, qui repose sur une megadosage de vitamine B1 (thiamine). Le neurologue italien Antonio Costantini traite plus de 2500) #ParkinsonsDisease #VitaminB1 #HealthInnovation #IT
Mark Zuckerberg and Priscilla Chan's Biohub is investing $500 million in a five-year initiative to create AI models of human cells, aiming to revolutionize disease research and treatment through open-access data while facing challenges in data scale and accuracy. #ArtificialIntelligence #Biotechnology #HealthInnovations #US #FR #DE #CN #JP #GB #IN
